Document is current
Any future updates will be listed below
-
Authors
Jeong, Soo-Kyung
Ham, Su-Jin
Baek, Seung-Hee
Jung, Eun-Jung
Jo, Hyun-Jin
Cha, Hye-Ran
Lee, Jae-Myun
Ahn, Byung Cheol
Yum, Jung Sun
Chun, Eunyoung
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 30 July 2024
First Online: 17 August 2024
Competing interests
: S.J., S.H., S.B., E.J., H.J., B.C.A., and E.C. are CHA Vaccine Institute employees. J.S.Y. is the chief executive officer of CHA Vaccine Institute. CHA Vaccine Institute holds worldwide license to a patent of Lipo-pam™ used in this study. CHA Vaccine Institute partially funded the study. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. No other authors declare any competing interests.
